tirzepatide in children Once Weekly and Adolescents with Type 2 Diabetes (SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 🚨 Breaking News in Pediatric

This international organization developed the GLP principles used in many countries today

The exact number of doses a patient needs may vary depending on their specific treatment plan and any adjustments made by their healthcare provider

The most common ones include nausea, vomiting, diarrhea and constipation, especially when you first start the medication

If you have diabetes and are taking insulin or sulfonylureas alongside GLP-1 therapy, be alert for hypoglycaemia symptoms and discuss dose adjustments with your healthcare team

If you prefer pieces that dont cling, look for A-line and swing dresses

Failing to disclose a condition or a medication youre on risks invalidating your policy, and you may end up paying full price for any treatment you receive if you suffer an emergency